Revenue growth for the September 2025 quarter compared with the June 2025 quarter was driven by a 66% increase in Ryoncil ® gross sales to US$21.9 million and 69% increase in net sales to US$19.1 ...

By Ayorinde Oluokun/AbujaThe Economic and Financial Crimes Commission (EFCC) said it have commenced investigations of 32 suspects arrested for suspected ponzi-style investment and employment scam at ...

Sanofi gained Rezurock in a $1.9 billion buyout of Kadmon in 2021, less than two months after the FDA approved the treatment ...

Sanofi (SNY) stock and Insmed (INSM) stock are in focus as new treatments from the companies win backing from an expert panel ...

Rezurock is already approved in 20 countries including the U.S., U.K. and Canada for the treatment of patients 12 years and older after at least two prior therapies failed, Sanofi said. It is approved ...

Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host diseaseParis, October 17, 2025. The European ...

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

A Chinese team has achieved a world first with a pig liver graft that functioned in a living recipient for more than a month, ...

While Sanders' injury is a blow to the Cowboys' running back group, it does also provide an opportunity for rookie ...

Ecuadorian state-run oil company Petroecuador is weighing a lawsuit against Vitol after the world's largest oil trader admitted last week to bribing officials in the South American country, according ...

Humacyte faces high volatility after Symvess approval positive trauma data but repeated dilutive fundraisings and safety ...

Kuros Biosciences’ released its MagnetOS minimally invasive spine delivery system in a full commercial launch. MagnetOS is a bone graft delivery system and is sterile, prefilled, free of human tissue ...